1. Pharmacological inhibition of monoacylglycerol lipase enhances IGM plasma levels and limits atherogenesis in a CB2-dependent manner. (August 2018) Authors: Guillamat-prats, R.; Rami, M.; Ring, L.; Rinne, P.; Lenglet, S.; Lauer, E.; Thomas, A.; Cravatt, B.; Weber, C.; Faussner, A.; Steffens, S. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗